Alessia Filippone

14PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markersCatalysis and mechanisms of reactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 11, 2026
Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040.

|Dec 17, 2024
Casein Kinase 2 Inhibitor, CX-4945, Induces Apoptosis and Restores Blood-Brain Barrier Homeostasis in In Vitro and In Vivo Models of Glioblastoma.

Valentina Bova, Deborah Mannino, Ayomide E Salako

|Nov 09, 2024
CK and LRRK2 Involvement in Neurodegenerative Diseases.

Valentina Bova, Deborah Mannino, Anna Paola Capra

|Aug 29, 2024
EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation.

Michela Campolo, Sarah Adriana Scuderi, Alessia Filippone

|Aug 29, 2024
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.

Valentina Bova, Rossella Basilotta, Giovanna Casili

|Mar 28, 2024
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza

Pageof 3

Frequent Collaborators

14 joint publications

Emanuela Esposito

8 joint publications

Salvatore Cuzzocrea

8 joint publications

Anna Paola Capra

6 joint publications

Sarah Adriana Scuderi